| Ines Fomaga Tsotezo, PHARMD | |
|
8316 Overbrook Rd, Leawood, KS 66206-1542 | |
| (316) 768-0098 | |
| Not Available |
| Full Name | Ines Fomaga Tsotezo |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 8316 Overbrook Rd, Leawood, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114483989 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-103227 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ines Fomaga Tsotezo, PHARMD 8316 Overbrook Rd, Leawood, KS 66206-1542 Ph: () - | Ines Fomaga Tsotezo, PHARMD 8316 Overbrook Rd, Leawood, KS 66206-1542 Ph: (316) 768-0098 |
News Archive
Kaiser Health News staff writer Phil Galewitz, working in collaboration with the PBS Newshour, reports: "The future of Medicaid - the state-federal workhorse of the nation's health system that provides health coverage to the poorest and sickest Americans - hangs in the balance on Election Day. President Barack Obama and Republican nominee Mitt Romney have vastly different approaches to the program."
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
National Eye Institute researchers profiling epigenomic changes in light-sensing mouse photoreceptors have a clearer picture of how age-related eye diseases may be linked to age-related changes in the regulation of gene expression.
In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.
For the first time, researchers have followed the development of blood vessels in zebrafish embryos without using any labels or contrast agents, which may disturb the biological processes under study.
› Verified 1 days ago
Dr. Jack R Bates, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9521 Mission Rd, Leawood, KS 66206 Phone: 913-383-2823 | |
Catherine Khalil, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4701 Town Center Dr, Leawood, KS 66211 Phone: 913-469-4014 | |
Mary K Wilson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2305 W 123rd Ter, Leawood, KS 66209 Phone: 816-588-2215 | |
Dr. David John Hanson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12122 State Line Rd, Leawood, KS 66209 Phone: 913-345-9377 | |
Tiana Williams, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5001 W 135th St, Leawood, KS 66224 Phone: 913-851-9903 | |
Dr. Jason S Kim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12724 Sagamore Rd, Leawood, KS 66209 Phone: 858-220-2615 |